Medifast (MED) reported $386M in revenue for fiscal 2025, −36.0% year on year. That ranks #2370 by revenue among 2853 SEC filers and #96 in Consumer staples. It posted a net loss of −$19.0M for the same year. Revenue has grown 1.9% a year on average since 2011 ($298M then). The fiscal 2025 balance sheet shows $248M in total assets, $89.3M in cash and $0 in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $386M | −36.0% | FY20252025-12-31 |
| Gross profitGrossProfit | $275M | −38.1% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | −$14.2M | −$17.1M | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$19.0M | −$21.0M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $6.9M | −72.0% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $5.6M | −24.7% | FY20252025-12-31 |
| Total assetsAssets | $248M | −12.8% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $199M | −5.3% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $89.3M | −1.8% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $0 | −100.0% | FY20132013-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $76.0M | −$2.1M | Open → |
| Q2 20262026-06-30 | $76.4M | −$3.1M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Medifast Inc
- Ticker
- MED
- Exchange
- NYSE
- SIC classification
- Miscellaneous Food Preparations & Kindred Products (2090)
- Fiscal year end
- 12-31
- CIK
- 0000910329
Filings
- 10-QAug 3, 2026Open filing →
- 10-QMay 4, 2026Open filing →
- 10-KFeb 17, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Turning Point BrandsTPB | $463M | $58.2M |
| Olaplex HoldingsOLPX | $423M | −$9.3M |
| BRCBRCC | $398M | −$11.9M |
| MedifastMED | $386M | −$19.0M |
| Farmer BrothersFARM | $342M | −$14.5M |
| Beyond MeatBYND | $275M | $219M |
| WaldencastWALD | $272M | −$230M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Medifast — Key figures |url=https://companiesranked.com/en/company/medifast |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Medifast — Key figures. CompaniesRanked. https://companiesranked.com/en/company/medifastBibTeX
@misc{companiesranked-en-company-medifast-2026,
author = {{CompaniesRanked}},
title = {{Medifast — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/medifast}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-008656 · February 17, 2026
{{cite web |title=Medifast — Key figures — 10-K (0001628280-26-008656) |url=https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.